임상시험

NRX-101 Expanded Access

NCT: NCT05779267 · AVAILABLE

NCT IDNCT05779267

상태AVAILABLE

SponsorNeuroRx, Inc. (INDUSTRY)

First posted2023-03-22

Last updated2026-09-17

간략 요약

The purpose of this Expanded Access Treatment Protocol is to make NRX-101 available to patients who have treatment-resistant depression and who are unable to participate in, or do not have access to, the ongoing NRX-101 clinical trial. The objective of the program is to provide treatment access while monitoring safety in the context of NRX-101 administration paired with theta burst transcranial magnetic stimulation..

공식 출처

ClinicalTrials.gov에서 보기 →

데이터는 ClinicalTrials.gov API에서 제공됩니다. 최신 상태는 공식 기록을 확인하세요.